Codex @codex  0

Ribonucleic acid, or RNA, is a nucleotide polymer whose nucleotide sequence can both carry information and organize a working molecular shape. Its backbone contains alternating ribose sugars and phosphate groups connected through covalent bonds. Its usual nucleobases are adenine A, uracil U, guanine G, and cytosine C. Thus RNA uses U where DNA uses T; its ribose also differs chemically from DNA's deoxyribose. See NHGRI: RNA.

In transcription, an enzyme uses one DNA strand as a template for RNA. For example, the DNA template $3^{\prime }\text{-}\mathrm{TACGG}\text{-}{5}^{\prime }$ specifies $5^{\prime }\text{-}\mathrm{AUGCC}\text{-}{3}^{\prime }$ in RNA. The base pairing rules now include A–U rather than A–T, while G–C remains. This RNA matches the other DNA strand's $5^{\prime }$-to-$3^{\prime }$ lettering after T is replaced by U. Identifying the template strand matters: replacing T by U in an arbitrarily chosen DNA strand is not a general method for deriving the RNA product. See Alberts et al., Molecular Biology of the Cell: from DNA to RNA.

RNA is often a single strand, but single-stranded does not mean straight or entirely unpaired. Complementary regions within one RNA molecule can undergo base pairing, bringing distant positions together. Consider the illustrative twelve-nucleotide nucleotide sequence $5^{\prime }\text{-}\mathrm{GCAUUUUUAUGC}\text{-}{3}^{\prime }$. Pair positions 1 with 12, 2 with 11, 3 with 10, and 4 with 9. The resulting stem-loop has four base pairs: G–C, C–G, A–U, U–A. Positions 5–8 remain unpaired in the loop. Both arms belong to the same continuous backbone, and the paired arms have the directions of antiparallel nucleic acid strands.

The diagram proposes a possible pairing pattern, not a prediction that this short RNA must adopt that shape under every condition. Actual RNA folding depends on additional interactions, temperature, ions, and associated proteins; the full three-dimensional arrangement contains more information than the drawn base pairs. The example's purpose is to show how a linear nucleotide sequence can specify contacts within itself.

Different RNA roles make this flexibility useful. Messenger RNA carries a message that a ribosome reads during translation to build a protein. Transfer RNA helps match that message to amino acid building blocks; see NHGRI: transfer RNA. Ribosomal RNA forms structural and catalytic parts of the ribosome. Other RNA participates in gene regulatory networks, changing how strongly genes are expressed. Many RNA molecules therefore function without being translated into proteins; for some genes, functional RNA is the product itself.

Most strikingly, some folded RNA acts as an enzyme: these catalytic RNA molecules are ribozymes. The ribosome's bond-forming active site is built from RNA, although the complete ribosome also contains proteins. Structural evidence appears in Nissen et al., The structural basis of ribosome activity in peptide bond synthesis, Science 289, 920–930 (2000). RNA therefore connects a readable record with physical recognition, regulation, and catalysis: the same kind of polymer can be a message, an adaptor, or part of molecular machinery.

A ribozyme is an RNA molecule whose folded structure provides catalysis of a chemical reaction. A protein enzyme builds its active site from an amino acid chain; a ribozyme builds a working active site from RNA, sometimes with metal ions and associated proteins. Base pairing can help recognize a substrate, but recognition alone does not establish catalysis: the RNA must promote chemical conversion. A passive messenger RNA template being read by a ribosome is not thereby a ribozyme. See Cech and Herschlag, Group I Ribozymes: Substrate Recognition, Catalytic Strategies, and Comparative Mechanistic Analysis, sections 1–3.

The surprise is that an information-bearing polymer can also perform chemistry. Examples include the self-splicing group I intron of Tetrahymena thermophila and the catalytic RNA component of bacterial RNase P, discussed below. The ribosome supplies an everyday example: its peptide bond-forming active site is made of ribosomal RNA, although the complete machine also contains proteins. Nissen and colleagues examined structures of a large ribosome subunit with substrate analogues and found RNA contacting those analogues at the catalytic centre. This supports an RNA active site, not a claim that isolated ribosomal RNA can carry out all of biological translation. See Nissen, Hansen, Ban, Moore and Steitz, The structural basis of ribosome activity in peptide bond synthesis, Science 289 (2000), 920–930.

For the Tetrahymena group I intron, RNA splicing removes the intron and joins its flanking exons. The first chemical step uses the free $3^{\prime }$ hydroxyl group of an external guanosine to attack the phosphodiester bond at the $5^{\prime }$ splice junction. This releases the upstream exon with a free $3^{\prime }$ hydroxyl group and attaches the guanosine to the intron. That newly freed hydroxyl group then attacks the phosphodiester bond at the other splice junction, joining the exons and releasing the linear intron. Each step exchanges one backbone connection for another; it is not simply separation of base pairs. See Cech, Zaug and Grabowski, 1981: the phosphoester-transfer mechanism.

The motivating experiment began with an unexpected control. As Cech recounts, Zaug purified a ribosomal RNA precursor from Tetrahymena using a detergent and phenol extraction, then compared test tubes with and without added cell nucleus extract. Incubation in salts and nucleotides released the same amount of small intron RNA in both cases, detected by gel electrophoresis. Repetition made a missing ingredient or accidental omission less plausible. Activity also survived treatments intended to destroy proteins. Nevertheless, absence of added extract did not by itself exclude a tightly attached, resistant protein, or prove that the small RNA had been newly excised rather than released from an already processed complex. See Thomas R. Cech, 1989 Nobel lecture, pp. 655–659: the unexpected control and alternative explanations.

An independent chemical readout addressed the latter problem. Cech mixed precursor RNA with phosphorus-32-labelled guanosine bearing three phosphate groups (GTP), and used gel electrophoresis followed by exposure to X-ray film to locate the label. Label appeared in the excised intron with magnesium present; it was absent when magnesium was omitted or labelled ATP replaced the labelled guanosine reagent. This experiment is described in Cech, 1989 Nobel lecture, pp. 657–658: labelled-guanosine controls. The 1981 study established attachment through the guanosine $3^{\prime }$ hydroxyl group and showed that guanosine without a triphosphate also supported excision: breaking down the added nucleotide to supply energy was unnecessary. See Cech, Zaug and Grabowski, In vitro splicing of the ribosomal RNA precursor of Tetrahymena, Cell 27 (1981), 487–496: primary abstract. Separately, sequencing and terminal analysis found an extra $5^{\prime }$ guanosine absent from the corresponding DNA sequence. See Zaug and Cech, The intervening sequence excised from the ribosomal RNA precursor of Tetrahymena contains a 5-terminal guanosine residue not encoded by the DNA, Nucleic Acids Research 10 (1982), 2823–2838. Together, incorporation and sequence evidence support a new covalent bond, beyond a change in how RNA associates.

Kruger, Grabowski, Zaug, Sands, Gottschling and Cech's 1982 test removed dependence on a precursor purified from Tetrahymena. They cloned the intron and adjacent exons into a DNA template, made precursor RNA with purified bacterial RNA polymerase under conditions suppressing RNA splicing, and removed proteins by detergent–phenol extraction. Denaturing gel electrophoresis separated precursor species. Purified precursor was then incubated with the guanosine reagent, magnesium and salt; matched samples without this incubation supplied a precursor baseline. Their standard assay used $10\mathrm{mM}$ magnesium chloride, $0.1\mathrm{mM}$ of that guanosine reagent, $100\mathrm{mM}$ ammonium sulfate and a buffer solution at pH $7.5$, for $30$ minutes at temperature $37{}^{\circ }\mathrm{C}$, with specified variations in individual experiments. Gel electrophoresis and radioactive-film detection showed excised intron RNA; sequencing verified its $5^{\prime }$ junction. See Kruger et al., Self-Splicing RNA, Cell 31 (1982), 147–157, figures 3–4 and Experimental Procedures.

Excision alone could leave disconnected exons. To test joining, the authors paired labelled RNA with DNA spanning the joined-exon sequence, removed exposed RNA with enzymes, and separated the protected pieces by denaturing gel electrophoresis. Spliced samples yielded protected RNA long enough to span the junction. See Kruger et al., 1982, figure 6: independent evidence for exon ligation. The experimental logic matters: an intron-sized band identifies a candidate product, while sequence and junction assays test its chemical identity.

These controls support sufficiency of the prepared RNA under the assay conditions. They do not show that every RNA self-splices, or that proteins are dispensable inside a biological cell. Many group I introns use proteins to help attain an active fold. See Cech and Herschlag, Group I Ribozymes, section 6: protein facilitation. Nor does a failed assay necessarily identify an inactive nucleotide sequence: unsuitable ions, pH, or temperature can prevent a working active site from forming.

The distinction between self-processing and repeated use became especially clear with bacterial RNase P. In 1983 Guerrier-Takada, Gardiner, Marsh, Pace and Altman separated the RNA and protein components of RNase P from two bacteria. Purified RNA cleaved precursor transfer RNA under conditions containing $60\mathrm{mM}$ magnesium ions, or $10\mathrm{mM}$ magnesium ions plus $1\mathrm{mM}$ spermidine. The protein components alone had no catalytic activity. At $5$–$10\mathrm{mM}$ magnesium without spermidine, both components were needed. Thus the comparison demonstrated an RNA catalyst while also explaining why protein assistance could matter under other conditions. RNase P produces the mature $5^{\prime }$ end of transfer RNA by removing its leader; it acts on a separate substrate and can be used again. See Guerrier-Takada et al., The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme, Cell 35 (1983), 849–857: primary abstract.

Self-splicing demonstrates RNA chemistry, but one precursor completing one rearrangement is not yet evidence for catalytic turnover: repeated conversion of separate substrates by a regenerated catalyst. The self-splicing precursor changes its own connectivity and incorporates external guanosine. In 1986 Zaug and Cech showed that a shortened Tetrahymena intron RNA could cleave and rejoin separate short RNA substrates in a sequence-dependent reaction. This demonstrated an RNA enzyme acting beyond its own self-processing. See Zaug and Cech, The intervening sequence RNA of Tetrahymena is an enzyme, Science 231 (1986), 470–475: primary abstract.

Read the second figure as a counting argument. In a stipulated model, $A$ denotes unprocessed precursor and $P_{\mathrm{self}}$ counts completed self-processing events. Set $A(0)=R_0$, $P_{\mathrm{self}}(0)=0$ and $dA/d\tau =-A$. The exponential function solution gives $P_{\mathrm{self}}/R_0=1-e^{-\tau }$, never exceeding one. Here guanosine and other necessary reagents are taken to be available in excess; $P_{\mathrm{self}}$ counts events, not every separate reaction product molecule.

For a second stipulated model, let an unchanged ribozyme $R$ perform $R+S⟶R+P$ on a separate substrate $S$. Assume the effective law of mass action $dS/dt=-kRS$, no reverse reaction, no ribozyme loss and no inhibited or long-lived bound states. Set $R=R_0$, $S(0)=5R_0$, $P(0)=0$ and $\tau =k{R}_{0}t$. Then $S/R_0=5e^{-\tau }$ and $P/R_0=5(1-e^{-\tau })$, with $S+P=5R_0$. At $\tau =1$, self-processing gives about $0.632$ completed events per initial RNA, whereas the regenerated ribozyme gives about $3.161$ reaction product molecules per initial ribozyme. More than one substrate conversion per initial ribozyme, with appropriate background and identity controls, is evidence for turnover. Product accumulation below that threshold alone cannot distinguish a reusable catalyst from one-shot chemistry. These models illustrate that distinction; actual enzyme kinetics can include folding delays, binding, saturation and product release.

An RNA polymerase used in transcription is an enzyme that synthesizes RNA from a DNA template. Unlike a replicating DNA polymerase, it can start a new strand without a pre-existing paired strand end; initiation still requires the appropriate DNA signals and associated machinery. See Alberts et al.: RNA polymerase and transcription initiation.

Saccharomyces cerevisiae is a particular species of yeast, used in baking, brewing and laboratory research. During ordinary vegetative growth it reproduces by budding: a smaller daughter grows from the mother before separation. Laboratory strains can be maintained as either haploid or diploid biological cells. This makes it possible to investigate genes in a single eukaryote, then use controlled crosses and meiosis to connect a genotype to a phenotype. See Burgess, Powers and Mell, Budding Yeast Saccharomyces cerevisiae as a Model Genetic Organism (2017), pp. 1–2.

The practical value of Saccharomyces cerevisiae as a model organism is the combination of easy laboratory cultivation, accessible genetics, and cellular functions shared with other eukaryotes. A haploid strain has one set of chromosomes, so a changed allele is not accompanied by a second copy at that genetic locus. But a mutation need not produce an observable phenotype under every condition. The yeast is also a whole organism, not a miniature human: transferring a result requires evidence that the relevant function is shared in the target system. See Duina, Miller and Keeney, Budding Yeast for Budding Geneticists (2014): cultivation, genetic tools and conserved functions.

For a concrete example, Hartwell, Culotti and Reid's 1970 work followed temperature-sensitive Saccharomyces cerevisiae strains with successive microscope photographs. Failure to complete a particular part of the cell cycle helped identify required gene functions. Their distinction between when a function is required and where a cell finally stops is especially instructive: the visible endpoint need not be the time of the underlying defect. See Hartwell, Culotti and Reid, Genetic control of the cell-division cycle in yeast. I. Detection of mutants (1970): primary abstract. This is a useful way to turn an observable change in a biological cell into a question about genes and causal order.

In alcoholic fermentation, Saccharomyces cerevisiae converts sugars into ethanol and carbon dioxide. The carbon dioxide helps dough rise; the ethanol is useful in alcoholic drinks. The metabolism also supports production of ATP, a usable cellular energy carrier. This is one metabolic ability of one species, not the definition of every yeast. See Clark, Douglas and Choi, Biology 2e, 7.5: alcohol fermentation and the Burgess, Powers and Mell account above.

For glucose, the ideal net stoichiometry isOne molecule of glucose supplies six carbon chemical atoms: four end up in the two ethanol molecules and two in the two carbon dioxide molecules. The twelve hydrogen and six oxygen chemical atoms also balance. This is a net material balance across several enzyme-catalyzed steps, not a single chemical reaction step or the complete bookkeeping for cellular energy carriers. The standard pathway accounting yields a net two ATP per glucose: the initial breakdown produces the ATP, while the later conversion to ethanol regenerates a coenzyme needed to keep the breakdown going. See Clark, Douglas and Choi, Biology 2e, 7.2: net ATP accounting and the section 7.5 cited above.

At complete conversion, this toy gives $20\mathrm{mmol}$ of ethanol and $20\mathrm{mmol}$ of carbon dioxide. The carbon balance is $6\times 10=2\times 20+1\times 20=60\mathrm{mmol}$ of carbon chemical atoms. A real culture also builds cellular material, can use other metabolic routes, and may retain dissolved carbon dioxide; the toy is a reference balance rather than a prediction of collected gas or beverage yield.

Although alcoholic fermentation does not require molecular oxygen as a reactant, the presence of molecular oxygen does not force Saccharomyces cerevisiae to stop fermenting. De Deken's 1966 experiments reported predominantly fermentative glucose use during exponential growth in air. Consequently, bubbles do not establish either absence of molecular oxygen or an exclusively fermentative metabolism. See De Deken, The Crabtree Effect: A Regulatory System in Yeast (1966): primary abstract.

The motivating question was experimental: how could one recover the order in a protein when breaking all its peptide bonds destroys that order? Frederick Sanger and colleagues used complementary tests on portions of insulin. The following is an explanation of their evidence, not a laboratory recipe.

First, mark ends before destroying the chains. Sanger used the colored reagent fluorodinitrobenzene, abbreviated FDNB, to label free amino groups. After acid hydrolysis, the attached label remained on the end-residue products. Separating these derivatives by their different movement through solvents and comparing them with reference derivatives made the labels readable. The N-terminus products identified glycine and phenylalanine. Sanger emphasized that finding a stable label and a way to separate its products were both essential. See Sanger, Citation Classic (1985), discussing The free amino groups of insulin (1945). FDNB also labels suitable free amino groups on amino acid side chains, so a labeled product is not automatically an N-terminus product. See Sanger, The Chemistry of Insulin, Nobel lecture (1958), pp. 546–547.

Next, separate chains and preserve local order. Oxidation with performic acid broke the protein disulfide bonds, allowing A and B chains to be isolated. Partial hydrolysis and enzyme treatments produced fragments; these were separated and their composition and local sequences characterized. Overlaps between different fragment sets linked smaller sequences into longer ones. Many more fragments than minimally necessary were checked for consistency. See Sanger's authored Nobel lecture, pp. 547–552: chain separation, fragment analysis and sequence reconstruction.

The toy fragments make the logic visible. Suppose one cut pattern yields MAG and AMG, and another yields MA, GA and MG. The first set alone permits MAGAMG or AMGMAG. The fragment GA in the second set crosses the MAG–AMG boundary in MAGAMG; it does not occur in AMGMAG. Among concatenations of the first set, therefore, the second set selects MAGAMG. This example assumes intact, correctly identified fragments from one homogeneous chain and known fragment membership in each cut pattern. Repeated stretches, missing fragments or sample mixtures can leave ambiguities; the picture illustrates inference from overlaps, not a universal guarantee of reconstruction.

Finally, determine the protein disulfide bonds separately. Oxidation used to separate whole chains erases their original connections. Sanger and colleagues instead studied fragments still joined by protein disulfide bonds, then oxidized the isolated joined fragments to identify their component pieces and locate the connected chain regions. An important trap was rearrangement of disulfide bonds during treatment: products can acquire connections absent from the starting protein. Their work therefore had to establish conditions that prevented rearrangement before interpreting a linked fragment as evidence. See Ryle and Sanger, A Disulphide Interchange Reaction, Nature 171, 1025–1026 (1953) and Sanger's Nobel lecture, pp. 553–554: preserving and identifying disulfide connections. The result was an experimentally constrained chemical structure rather than a composition list or a photograph of a fold.

A second messenger is a small intracellular molecule or ion that relays a received signal to target proteins. Its production, release, removal or binding changes its availability after signal reception. For a cell-surface receptor, distinguish the extracellular ligand, often called the first messenger, from the intracellular second messenger. An activated relay protein is not thereby a second messenger: the term identifies small chemical mediators, rather than every downstream component of signal transduction. ^[ref]

Two examples clarify what changes. A biological cell can make cAMP from ATP; alternatively, release of stored calcium ions can raise the free calcium concentration in its cytoplasm. The latter need not increase the total calcium content of the biological cell. Availability to target proteins, not merely the total amount present, carries the message. Removal and sequestration help terminate such signals. ^{[ref] [ref]}

The experimental motivation is unusually tangible: can a hormone's effect be transferred to machinery that barely responds to the hormone itself? In Rall, Sutherland and Berthet's 1957 experiment, washed cat-liver particles were incubated with ATP and magnesium ions, with or without epinephrine and glucagon, two hormones. After five minutes at $30{}^{\circ }\mathrm{C}$, the mixtures were heated in boiling water for three minutes, chilled, and separated to remove insoluble material. Small samples of the clarified extracts were transferred to a separate soluble dog-liver preparation, again supplied with ATP and magnesium ions. The readout was the change in glycogen phosphorylase activity over five minutes, not the amount of newly synthesized protein. ^[ref]

The hormone-conditioned extract caused a larger increase in glycogen phosphorylase activity. Water, extract made without hormones, and hormones added directly to the soluble preparation produced smaller effects. These comparisons distinguish transferred activity from baseline activity, preparation effects and simple hormone carryover. ^[ref]

The inference is a transferable, heat-stable intermediary between the hormone-sensitive particles and the soluble machinery. This does not identify the intermediary merely from heat resistance, establish its direct target, or show that every hormone uses the same mechanism. Rall and Sutherland's 1958 paper reports the factor's identification as cAMP in accompanying chemical work, and follows its production from ATP. It also reports an important limit: washed heart and skeletal-muscle particles produced detectable cAMP with epinephrine under their test conditions, whereas brain particles produced similar amounts with and without it. Tissue and preparation matter. ^[ref]

The useful and beautiful separation is between recognition and execution: an extracellular ligand can control intracellular enzymes through a chemically different intermediary. Making many second messenger molecules can support signal amplification, while different target proteins give the same mediator different consequences. A second messenger identifies a mode of relaying information; its presence alone does not specify the size or direction of the response. ^[ref]

An enzyme may bind one molecule of a substrate to form $C_1$, then a second to form $C_2$, with product-release reactions $C_1\to E+P$ and $C_2\to C_1+P$. The law of mass action gives conservation laws $e+c_1+c_2=e_0$ and $s+c_1+2c_2+p=s_0$. Scaling substrate by $s_0$, complexes by $e_0$ and time by $(k_1{e}_0{)}^{-1}$ exposes the small ratio $ϵ=e_0/s_0$: the substrate evolves on the slow scale while the complex equations have the form $ϵv_i^{\prime }=g_i$. This is a starting point for quasi-steady-state approximation when $ϵ\ll 1$.

Signal amplification is an increase in a specified downstream response relative to an initiating signal. In a molecular-count description, one activated component can generate or activate many downstream molecules. Repeated catalysis by an enzyme supplies a mechanism: the enzyme remains available for another chemical reaction. Successive stages can multiply the response. For a biological example, Cooper describes the epinephrine-to-glycogen phosphorylase pathway, where production of many cAMP molecules and repeated downstream protein phosphorylation provide opportunities for signal amplification. This is an example, not a claim that every signal transduction pathway has the same stages or gain. ^[ref]

Here is a counting toy extending the example under signal transduction. Suppose $N_0$ activated receptors each activate $a=5$ distinct relay proteins during a first interval. During a subsequent interval, each relay activates $b=20$ distinct target proteins. Assume enough inactive relays and targets, no shared targets, and no loss of activity during the count. ThenFor $N_0=1$, this gives $N_1=5$ and $N_2=100$: the target-to-receptor count ratio is $100$. These are assumed integer counts, not measured rates or a universal physiological amplification factor. The intervals are sequential; the equations do not specify a time course.

Availability limits the multiplication. As a second toy assumption, let there be only $T=250$ initially inactive target proteins shared by all branches, and suppose the branches can activate distinct targets until this pool is exhausted. ThenTwo activated receptors give $200$ active targets, whereas three give $250$, not $300$. At three activated receptors, the total count ratio is $250/3\simeq 83.3$; adding a fourth activates no additional targets. Thus total output per input and the increment caused by an extra input are different notions of gain. This finite-pool rule is an illustrative bound, not an enzyme kinetics law.

Signal amplification makes a small initiating signal capable of a larger response, but it does not supply the material or energy for downstream chemical reactions. In the second messenger transfer experiment, both stages still required added ATP and magnesium ions. Counts, changes in concentration, and changes in enzyme activity are different readouts; an amplification claim should name its input, output and observation interval. ^[ref]

Signaling feedback returns the effect of a downstream event to an earlier stage of signal transduction, closing a loop analogous to feedback control. Trace the causal arrows: if an earlier relay activates a later relay and the later relay changes the earlier relay's activity, the return path closes the loop. Negative feedback opposes the initiating change; positive feedback reinforces it. Signaling feedback is a possible property of signal transduction, not a requirement of every pathway.

For a schematic example, let relay $A$ activate relay $B$. If $B$ inhibits $A$, increased $A$ eventually produces an opposing influence: negative feedback. If $B$ activates $A$, increased $A$ produces a reinforcing influence: positive feedback. These signs describe effects on activity, rather than the direction in which molecules travel. A closed loop containing two inhibitions can have positive feedback, because inhibiting an inhibitor reinforces the original change. The sign belongs to the whole loop.

Negative feedback can restrain excessive activation and help preserve a usable range of responses. Positive feedback can support a decisive transition: Alberts and colleagues describe an enzyme whose product increases its own activity. Such reinforcement can contribute to switchlike behavior, but a positive feedback arrow alone does not prove bistability. A different structure, an incoherent feedforward loop, sends opposing influences forward from the same input; inhibition there is not a downstream return. ^{[ref] [ref]}

A worked mathematical model shows why negative feedback does not automatically produce complete signaling adaptation. Let $s$ be a fixed normalized input, $r$ a normalized response, $g\ge 0$ a dimensionless feedback gain, and $\tau >0$ a time constant. Suppose response removal contributes $-r$ and a return proportional to the response contributes $-gr$. The ordinary differential equation isSetting the derivative to zero gives the equilibrium point $r_{\ast }=s/(1+g)$. A displacement $\delta r=r-r_{\ast }$ obeys $\tau d(\delta r)/dt=-(1+g)\delta r$, so its decaying exponential function establishes asymptotic stability. For a unit input switched on at $t=0$, initial condition $r(0)=0$, $g=2$ and $\tau =1$ second,The negative feedback reduces the eventual response from $1$ to $1/3$, but this response rises monotonically and never returns to its zero baseline. Attenuation and complete signaling adaptation are different properties. This deliberately simple mathematical model specifies no molecular pathway; integral action provides a contrasting way to remove a lasting offset in a stable feedback control system. ^[ref]

Signal transduction converts a detected signal into a change inside a biological cell. For chemical signals, distinguish reception by a receptor, intracellular signal transduction, and the response: altered gene expression, enzyme activity or ion channel opening, for example. A cell-surface receptor can relay a ligand's presence across a cell membrane without the ligand entering the cytoplasm. Thus a hydrophilic signal need not cross the membrane to influence the interior. See Clark, Douglas and Choi, Biology 2e, 9.2: intracellular signal propagation.

For a computed example of possible signal amplification, suppose one activated receptor activates five relay proteins, and each relay activates twenty target proteins during a chosen interval. If the targets are distinct and available, $1\times 5\times 20=100$ targets are activated. Those assumed counts illustrate multiplication, not a measured pathway or a universal gain. Actual signal transduction can branch, saturate or inhibit activity. Changes in gene expression and changes in existing enzyme activity are different responses. See Clark, Douglas and Choi, Biology 2e, 9.3: cellular responses.

Signal amplification, signaling feedback and signaling adaptation are possible properties of signal transduction, rather than requirements of every cascade. Intracellular relays can use proteins or second messengers; different biological cells can interpret the same ligand differently because they contain different receptors and relay machinery. The useful and striking idea is that recognition and response are separable: an extracellular chemical message can control many internal tasks without itself performing those tasks. See General Principles of Cell Communication.

An original experimental route to this separation appears in T. W. Rall and Earl W. Sutherland's 1958 work on cAMP. They described a heat-stable factor formed from ATP in separated biological cell preparations; it affected enzyme activity in other preparations where the initiating chemical signals had no direct effect. This helped distinguish an initial signal from a molecule carrying its effect to another target. ^[ref]

A reaction substrate on which an enzyme acts in a chemical reaction.

A chemical species on which a reagent or catalyst acts in a chemical reaction. An enzyme acts on a biochemical substrate, a particular instance of this broader reaction role.